A graduate of Harvard University, she has written for NY Magazine, Live Science, Vice, Fox News, and other out
Semaglutide may increase risk for NAION, but current data remain insufficient for causal conclusions
References Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ
Mounjaro is mostly given to people with type 2 diabetes to help control blood sugar
Forty-seven subjects were recruited and randomly assigned to the placebo ( n = 24) and to the LC ( n = 23) groups
A comparison between the three studied medications revealed more fatal adverse events associated with liraglutide (8 patients had a fatal outcome out of 147 ICSR) compared with semaglutide (one death out of 210 ICSR) and none with tirzepatide (out of 15 ICSR)